Patent · US Expired

Minimising body weight gain in insulin treatment

US8003605B2 · kind B2 · utility

15Cited by

3References

13Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Thomas Bayer · Igersheim, DE
Birgitte Sogaard · Gilleleje, DK
Mads Axelsen · Avenue Madeleine, DK

Key dates

Filing date	Mar 12, 2003
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Nov 25, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for minimizing weight gain, preventing weight gain or inducing weight loss in a mammal, said method involving a treatment regimen which comprises administration of an insulin derivative having a substituent containing from 6 to 40 carbon atoms attached to one of its amino acid residues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.